جستجوی استاد راهنمای دانشگاهی

Hai-Quan Mao is a Professor of Materials Science and Engineering at Johns Hopkins University, with a joint appointment in the Biomedical Engineering Department (School of Medicine). He directs the Institute for NanoBioTechnology (INBT) and leads the Translational Tissue Engineering Center. His research focuses on biomaterials, regenerative engineering, and immunoengineering, particularly developing nanomaterials for therapeutic delivery and tissue regeneration. Mao holds 35 U.S. patents, co-founded two biotech companies, and received prestigious awards including National Academy of Inventors Fellow and NSF CAREER Award. Education: BS in Chemistry (1988) and PhD in Polymer Chemistry (1993) from Wuhan University. Postdoctoral training at Johns Hopkins (1995–1998), followed by roles at Johns Hopkins Singapore (1999–2003) before joining the Whiting School faculty. Research emphasizes nanofiber scaffolds for liver/nerve regeneration, DNA/lipid nanoparticle engineering for gene therapy, and artificial lymph node matrices for immunotherapy. His lab translates biomaterials innovations into clinical applications, with NIH-funded projects addressing cancer, malaria, and tissue damage. Awards include over 60 provisional patents, multiple Johns Hopkins translational awards, and Thalheimer Awards for research. He serves as associate editor of Biomaterials and editorial board member of major journals. Lab activities include scalable nanoparticle manufacturing, machine learning for material design, and collaborations with industry/clinical partners. Recent work includes lipid nanoparticle optimization for mRNA vaccines and exosome-based therapies for Crohn’s disease.

• Biomaterials
• Regenerative Engineering
• Therapeutic Delivery
• +۳ مورد دیگر

Theresa Raimondo is the Manning Assistant Professor of Engineering at Brown University, with a secondary appointment in the Division of Biology and Medicine. She joined the Brown Engineering faculty in January 2024 after completing her postdoctoral training at MIT's Koch Institute. Dr. Raimondo leads the Raimondo Research Lab, which focuses on chemically modifying RNA and designing nanoparticles for therapeutic delivery to the body, an immunotherapy concept that holds immense promise in the field of immunoengineering. Her educational background includes: PhD in Engineering Sciences – Bioengineering from Harvard University (2019) MEng from Harvard University (2019) Sc.B. in Chemical and Biochemical Engineering from Brown University (2011) Dr. Raimondo's research is broadly focused on the design of targeted drug-delivery vectors and novel RNA-based therapeutics for applications in cancer, immunotherapy, and tissue regeneration. Her work primarily centers on developing novel lipid nanoparticles (LNPs) for RNA-based therapies, contributing to adjuvanted mRNA-based vaccines and siRNA-based cancer immunotherapies. By optimizing LNP formulation and modulating RNA constructs, she seeks to understand how RNA-LNPs modulate immunity and develop new therapeutic approaches. Her expertise spans biomaterials, drug delivery, biomolecular engineering, nanomedicine, tissue engineering, and regenerative medicine. Analysis of Dr. Raimondo's recent publications reveals a strong focus on RNA delivery systems and lipid nanoparticle technology. Her work spans from fundamental studies on nanoparticle design to applications in cancer immunotherapy, vaccine development, and tissue regeneration. A significant portion of her research involves optimizing lipid formulations for improved mRNA delivery and exploring how these systems interact with the immune system. Her publications demonstrate a trajectory from basic biomaterials research to increasingly translational work with therapeutic applications. Dr. Raimondo has received numerous prestigious awards: 2025 NAE Symposium selection (Grainger Foundation Frontiers of Engineering) 2025 appointment to the inaugural Early Career Board of ACS Applied Bio Materials 2024 selection as MIT Faculty Founder Initiative finalist 2022 Convergence Scholar fellowship from MIT's Marble Center for Cancer Nanomedicine National Science Foundation graduate research fellowship Harvard's Smith family graduate fellowship Dr. Raimondo is actively involved in mentoring students through courses including ENGN 0931L - Biomedical Engineering Design and Innovation II, ENGN 1490 - Biomaterials, and ENGN 1931L - Biomedical Engineering Design and Innovation II. Her research program is supported by various grants, though specific funding sources aren't detailed in the provided text. The Raimondo Research Lab represents a dynamic environment where engineering principles are applied to solve complex biological challenges in drug delivery and regenerative medicine. The Raimondo Research Lab at Brown University serves as a hub for innovation in RNA delivery and biomaterials design. The lab brings together expertise in chemical engineering, molecular biology, and immunology to develop next-generation therapeutic platforms. Current research directions include optimizing lipid nanoparticle formulations, exploring novel RNA modifications, and investigating immune responses to RNA therapeutics across various disease contexts.

• Biomaterials
• Drug Delivery
• RNA-based Therapeutics
• +۵ مورد دیگر

Dr. Kathryn A. Whitehead is a Professor in the Department of Chemical Engineering and holds a courtesy appointment in the Department of Biomedical Engineering at Carnegie Mellon University. She joined the faculty in 2012 after completing postdoctoral training at MIT. Her research focuses on engineering drug delivery systems for RNA therapeutics, maternal-infant health, and overcoming biological barriers to enhance drug efficacy. Key areas include lipid nanoparticle (LNP) design for mRNA delivery, intestinal permeation enhancement, and leveraging maternal milk cells for therapeutic applications. Education: H.B.Ch.E., University of Delaware (2002); Ph.D., University of California, Santa Barbara (2007); Postdoctoral Fellow, MIT (2008–2012). Research Interests: Drug delivery systems, RNA interference, bionanotechnology, personalized medicine, and translational nanomedicine for diseases such as cancer and diabetes. Her lab develops novel LNPs for targeted delivery to tissues like the liver, brain, and pancreas. Awards and Recognition: AIMBE Fellow, DARPA Young Faculty Award (2016), CMBE Young Innovator Award (2016), MIT Technology Review Innovator Under 35 (2014), and NIH Director’s New Innovator Award. Her work has been cited over 9,000 times, with patents in RNA delivery and permeation enhancers. Lab Members: Active researchers include Ph.D. students, postdocs, and undergraduates working on projects such as LNP formulation, maternal milk cell biology, and siRNA therapies. Notable alumni have advanced to roles at Moderna Therapeutics, Verve Therapeutics, and academic institutions. Grants and Funding: Supported by NIH, DARPA, and industry partnerships. Current projects include NIH grants on pregnancy-safe mRNA delivery and DARPA funding for maternal-infant therapeutics.

• Drug Delivery
• RNA Therapeutics
• Bionanotechnology
• +۴ مورد دیگر

Ulrich Lächelt is an Assistant Professor in the Department of Pharmaceutical Sciences at the Faculty of Life Sciences. His research focuses on nanoparticle technology, drug delivery systems, and gene therapy, with a particular emphasis on CRISPR/Cas9 genome editing and RNA-based therapeutics. He leads a project on nanoformulations of prime editing ribonucleoproteins (2025–2029), aiming to advance precision medicine. His work contributes to UN Sustainable Development Goals, particularly in health and innovation. Research Interests: Nanoparticle design and material science CRISPR/Cas9 delivery systems siRNA and mRNA therapeutic formulations Cancer-targeted drug delivery Biomedical engineering applications Publications (2025–2023): Highlighted studies include dual pH-responsive CRISPR delivery systems and accelerated endosomal escape mechanisms. His work spans 40+ peer-reviewed articles, with recent trends focusing on xenopeptide carriers and tumor-targeted therapies. Grants & Projects: Current research funding includes a nanoformulations project (2025–2029). He actively collaborates on international initiatives, with recent presentations at global conferences on CRISPR delivery and gene editing strategies. Labs/Teams: Involved in interdisciplinary teams developing novel drug delivery platforms and screening tools for prime editor RNPs.

• Nanoparticle Technology
• Pharmaceutical Sciences
• Material Science
• +۳ مورد دیگر

Justin Milner, PhD, serves as Assistant Professor in the Department of Microbiology and Immunology at the University of North Carolina at Chapel Hill School of Medicine and is a member of the UNC Lineberger Comprehensive Cancer Center. His research develops novel approaches to enhance cancer immunotherapies through multi-omics and bioengineering techniques. Education: Postdoctoral Fellowship, UCSD PhD, UNC Chapel-Hill BS, UNC Chapel-Hill Dr. Milner's lab investigates molecular drivers of T cell differentiation and function within tumor microenvironments, utilizing cutting-edge genomics, bioengineering, and computational immunology. His work focuses on reprogramming T cell activity to overcome immunotherapy resistance in cancers, with particular emphasis on epigenetic regulation and metabolic adaptations of tumor-infiltrating lymphocytes. Recent projects explore hydrogel-based delivery systems for immunotherapeutics and transcriptional networks governing T cell exhaustion. Analysis of his 15 most recent publications reveals dominant themes in cancer immunotherapy enhancement, particularly through T cell engineering (7/15 articles), tumor microenvironment modulation (5/15), and computational approaches to T cell biology (3/15). Key methodologies include single-cell multi-omics, in vivo screening, and biomaterial-based drug delivery systems targeting solid tumors. Scientific Awards: NIH NCI K99/R00 Pathway to Independence Award V Foundation Scholar Award Lung Cancer Initiative Career Development Award UNC Lineberger Innovation Award Multiple institutional pilot awards including Hirschberg Foundation and Mary Kay Ash Awards Dr. Milner currently advises three graduate students and multiple postdoctoral researchers while leading an NIH-funded R01 project ($2.79 million) investigating epigenetic regulation of T cell exhaustion. His lab maintains active collaborations across computational medicine and pancreatic cancer research programs at UNC. The Milner Lab operates within the UNC Lineberger Comprehensive Cancer Center, utilizing core facilities for single-cell genomics, murine tumor modeling, and bioengineering. Current team includes seven researchers focused on T cell reprogramming strategies for solid tumor immunotherapy.

• Cancer Immunotherapy
• T Cell Biology
• Tumor Microenvironment
• +۵ مورد دیگر

Dr Marten Moore is a Research Fellow at the Division of Plant Sciences, The Australian National University. His research focuses on understanding mRNA dynamics, plant stress responses, and photosynthesis efficiency through molecular and genetic approaches. He investigates how plants adapt to environmental stresses such as light fluctuations and salinity, with a particular emphasis on retrograde signaling pathways linking chloroplasts to nuclear responses. Dr Moore’s work integrates experimental and computational methods, including the development of tools like ConCysFind for analyzing conserved protein sequences across plant species. He collaborates on projects aimed at enhancing crop resilience through improved energy use efficiency and yield stability, leveraging insights from wheat and Arabidopsis models. Key Projects: Using RNA regulation to improve energy use efficiency and boost yield in wheat (2024–2027) Regulators of protein translation reveal new pathways to plant productivity (2022–2025) Smart Plants and Solutions for Enhancing Crop Resilience and Yield (2021–2025) His research interests span mRNA fate during stress recovery, nitric oxide signaling in plant cells, and the role of glutathione peroxidases in symbiotic root nodules. Dr Moore’s contributions bridge fundamental plant biology with applied agricultural challenges, aiming to translate molecular insights into practical solutions for sustainable agriculture.

• Plant Physiology
• Molecular Biology
• RNA Processing
• +۴ مورد دیگر

Prof Wen Wang is Professor of Biomedical Engineering and Vice-Principal and Executive Dean for Science and Engineering at Queen Mary University of London, affiliated with the School of Engineering and Materials Science and the Centre for Bioengineering. He is a Chartered Engineer and holds fellowships from the Institution of Mechanical Engineers (FIMechE), Higher Education Academy (FHEA), American Institute for Medical and Biological Engineering (FAIMBE), and the Royal Academy of Engineering (FREng), reflecting his leadership and technical excellence in engineering and biomedical sciences. His research focuses on vascular bioengineering , biomaterial mechanics , and cell biomechanics , with particular emphasis on the endothelial glycocalyx , vascular stem cells , and transmembrane transport . He employs advanced techniques such as AFM nano-indentation, confocal microscopy, and microfluidic platforms to study the mechanical properties, shear stress responses, and structural stability of biological systems. His work spans from fundamental biophysics to translational applications in drug delivery and cardiovascular disease. Prof Wang has led multidisciplinary research projects in the UK and through international collaborations with partners in the US, China, and Japan. His recent publications highlight sustained contributions to understanding microcapsule mechanics , extracellular vesicles , biofluid dynamics , and biomolecular sensing . His work integrates experimental and computational modeling, particularly in microcirculation and cellular transport phenomena. He has received notable scientific recognition through multiple prestigious fellowships and has published extensively in high-impact journals including Nature Communications , Journal of Controlled Release , Biosensors and Bioelectronics , and Journal of Fluid Mechanics . His research demonstrates a strong trajectory in both fundamental discovery and applied biomedical innovation. Prof Wang actively supervises research and collaborates with clinical and engineering partners at Queen Mary and King's College London. His leadership in the School of Engineering and Materials Science underscores his role in shaping academic strategy and research excellence in science and engineering at Queen Mary University of London.

• Biomedical Engineering
• Vascular Bioengineering
• Biomaterial Mechanics
• +۱۴ مورد دیگر

Michelle Farkas is an Associate Professor in the Department of Chemistry at the University of Massachusetts Amherst. Her work bridges chemical biology, synthetic chemistry, and cancer biology to develop molecular tools for studying circadian rhythms and macrophage phenotypes in oncology contexts. Affiliated with the Graduate Program in Molecular & Cellular Biology Faculty member at the Center for Bioactive Delivery and Models to Medicine within the Institute for Applied Life Sciences Research focuses on: Designing reporters and modulators for circadian rhythms in cancer models Engineering macrophages for anti-cancer polarization and targeted delivery Developing chemically modified cells and nanozymes for therapeutic/diagnostic applications Scientific contributions include chemical modulation of circadian clocks, bioorthogonal nanozyme systems, and novel cell-based delivery platforms. Her recent publications highlight interdisciplinary approaches combining synthetic chemistry with cancer immunology. DOD-BCRP Postdoctoral Fellow Current projects aim to translate molecular tools into clinical diagnostics and therapies, leveraging collaborations across chemistry, biology, and medicine.

• Chemical Biology
• Cancer Biology
• Circadian Rhythms
• +۴ مورد دیگر

Richard Katz, PhD, is a Professor and Adjunct Professor at the Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, based at Fox Chase Cancer Center. His research focuses on epigenetic regulation in cancer, particularly the role of the nuclear lamina in organizing heterochromatin and gene silencing. PhD in Microbiology, Columbia University (1983) BS in Biology, Summa cum laude, Syracuse University (1975) Dr. Katz's research spans several key areas in epigenetics and cancer biology. He investigates how the nuclear lamina controls epigenetic silencing through proteins like PRR14, which tethers heterochromatin to the nuclear periphery. His lab uses siRNA-based genome-wide screens to identify novel epigenetic silencing networks. Another major focus is melanoma plasticity, where his team discovered ID4 as a key mediator. He also studies epigenetic antiviral responses involving Daxx and retroviral silencing, and functional analysis of breast cancer genes from GWAS and DASE studies using BioID for protein interaction mapping. His recent publications reveal a strong trend in understanding chromatin dynamics, epigenetic silencing mechanisms, and their implications in cancer and viral defense. His work integrates molecular biology, functional genomics, and systems approaches to dissect complex regulatory networks. Notable scientific recognitions include being selected for Cover Art in Epigenetics (2014) and an Article of Significant Interest by the editors of Journal of Virology (2013). Dr. Katz actively mentors students and technicians in his lab, including graduate students and post-baccalaureate researchers. He collaborates widely across Fox Chase, including with J.P. Issa, A. Bellacosa, and A.M. Skalka. His lab participates in the Undergraduate Summer Research Fellowship and research volunteering programs, indicating a strong commitment to training and education. His lab at Fox Chase (R422/W422) includes current members such as Valentina Medvedeva (Graduate Student), Trinity Pellegrin (Scientific Technician), and several student assistants, reflecting an active and collaborative research environment.

• Epigenetic Regulation
• Cancer Epigenetics
• Nuclear Lamina
• +۷ مورد دیگر

Andrew Care is a Senior Lecturer and Academic Director of the Biologics Innovation Facility (BIF) at the University of Technology Sydney (UTS), within the School of Life Sciences. He holds a PhD in Chemistry and Biomolecular Sciences from Macquarie University and has held prestigious fellowships, including the Cancer Institute NSW Early Career Fellowship and UTS Chancellor's Research Fellowship. His research focuses on combining synthetic biology and nanomedicine to engineer biologically-derived nanoparticles for drug delivery and vaccines. He is actively involved in industry collaborations, notably as a Chief Investigator in the ARC ITRC IDEAL Hub. Teaching and leadership roles include Program Director for the Biomedical Engineering program and coordination of the Australasian Synthetic Biology Challenge, which fosters student innovation. He has been recognized with a UTS Vice-Chancellor’s Teaching Citation and multiple Dean’s Awards for integrating Work Integrated Learning (WIL) and enhancing student engagement. His contributions to education and research excellence have earned awards for collaboration and partnership. Research interests span nanoparticle engineering, neurodegenerative disease therapies, and biomanufacturing. Notable projects include developing an Alzheimer’s vaccine using encapsulin protein cages and investigating nanoparticle interactions in brain cells. His work bridges academia and industry, emphasizing translational applications in healthcare. Awards: UTS Vice-Chancellor’s Research Excellence Award (2024), UTS Teaching Citation (2024), Multiple Dean’s Awards for Science Initiative, Innovation, and Student Experience. Leadership: Academic Lead of BIF, Editor of SYNTHESIS Magazine, and EMCR Representative in research committees. Grants: Providence Foundation Project Grant (2023), ARC IDEAL Hub funding. Andrew’s labs, including the Biologics Innovation Facility, provide advanced training in biomanufacturing and nanomedicine, equipping students and professionals for industry roles. His research aims to address unmet clinical needs through innovative biomedical solutions.

• Nanomedicine
• Synthetic Biology
• Drug Delivery Systems
• +۳ مورد دیگر

Zoran Gajic is a Professor of Electrical and Computer Engineering at Rutgers University, where he has taught since 1984. He holds academic leadership roles including Graduate Program Director for the Electrical and Computer Engineering Department and President of the Rutgers AAUP-AFT Faculty Union. His expertise spans controls systems, energy systems (including solar, wind, and smart grids), wireless communications, and networking. Education: B.S. and M.S. in Electrical Engineering from University of Belgrade, followed by M.S. in Applied Mathematics and Ph.D. in Systems Science Engineering from Michigan State University (1984). Research focuses on control theory applications for energy systems and communication networks. He has authored/coauthored nearly 100 journal papers and eight books, including best-selling titles like Linear Dynamic Systems and Signals (translated into Chinese) and Lyapunov Matrix Equation in Systems Stability and Control (republished by Dover). His work includes innovations in multirate control systems, singular perturbation methods, and reinforcement learning applications. Professional recognitions include editorial roles across nine journals, five guest-edited special issues, and plenary lectures at international conferences. Ten of his 17 Ph.D. advisees hold faculty positions globally. Beyond academia, he is a chess master with Life Master ranking from the U.S. Chess Federation and World Chess Federation certification. Key contributions include foundational work on optimal control for renewable energy systems, sliding mode control algorithms, and system decomposition techniques. His research has been supported by NSF and industry partners like AT&T Bell Labs. He leads the Rutgers Center for Systems and Controls (SYCON) as Associate Director and actively contributes to standards through IEEE and IEC initiatives, particularly in power system protection and control system reliability.

• Control Systems
• Energy Systems
• Wireless Communications
• +۴ مورد دیگر

Prof. Dr. Sven-Erik Behrens serves as a Professor in the Department of Microbial Biotechnology at the Faculty of Natural Sciences I of Martin Luther University Halle-Wittenberg. He is affiliated with the Protein Research Center 'Charles Tanford' and maintains an active research program focused on RNA biology, molecular virology, and biotechnological applications. His primary research interests encompass RNA-based plant protection strategies, viral replication mechanisms (particularly for flaviviruses and plant viruses), and innovative vaccine development using Kluyveromyces lactis yeast expression systems. Behrens' work investigates fundamental RNA-protein interactions, RNA chaperone activities, and the molecular basis of antiviral defense mechanisms in plants. His laboratory explores how RNA accessibility influences viral replication and how this knowledge can be harnessed for developing novel RNA-based antiviral strategies. Analysis of his recent publications (2021-2025) reveals a clear research trajectory focused on identifying accessible RNA sites for targeted antiviral applications, optimizing yeast-based vaccine platforms for both plant and animal pathogens, and investigating the role of non-coding RNAs in plant development and stress responses. His work spans multiple disciplines including plant virology, medical virology, and microbial biotechnology, demonstrating translational research from basic molecular mechanisms to practical applications. Prof. Behrens leads research in the Department of Microbial Biotechnology, collaborating with various groups working on plant-pathogen interactions and vaccine development. His laboratory employs advanced techniques including RNA structure probing, fluorescence-based assays for RNA chaperone activity, and plant in vitro systems for studying viral replication. The research demonstrates significant potential for developing novel approaches to combat viral diseases in both agricultural and medical contexts.

• Molecular Virology
• RNA Biology
• Plant Biotechnology
• +۵ مورد دیگر

Dr. Anna Barnard is an Associate Professor (Senior Lecturer) in the Department of Chemistry at Imperial College London, affiliated with the Institute of Chemical Biology and multiple research groups including the Barnard Group. Her research focuses on developing chemical tools to target protein-protein interactions (PPIs), with applications in infectious diseases, cancer, and antibiotic resistance. She holds a Wellcome Trust Sir Henry Dale Fellowship (2019-2025) and leads a multidisciplinary team in drug discovery, peptide engineering, and chemical biology. Education: PhD in Chemistry (University of York, 2012), postdoctoral training at the University of Leeds, Imperial College London, and a Junior Research Fellowship at Imperial (2015). She has authored over 30 publications in journals like Chemical Science , Journal of the American Chemical Society , and ACS Chemical Biology . Research Interests: Design of helix mimetics, stapled peptides, and small molecule inhibitors; targeting bacterial toxins (e.g., Doc in Salmonella); malaria transmission-blocking agents; and applications of molecular rotors for live-cell imaging of PPI inhibition. Her work bridges organic chemistry, synthetic biology, and translational medicine. Awards: Wellcome Trust Sir Henry Dale Fellowship, Imperial College Network of Excellence in Malaria. Collaborations include Imperial’s Department of Medicine, the Institute of Infection, and industry partners like FreshCheck. She mentors over 20 current and past students, including PhD candidates and MRes researchers. Labs/Teams: Barnard Group (Chemical Biology), Institute of Chemical Biology (CDT in Chemical Biology), and cross-disciplinary initiatives with the Kuimova, Fuchter, and Tate groups. Research is funded by Wellcome Trust, EPSRC, and Imperial College scholarships.

• Medicinal and Biomolecular Chemistry
• Organic Chemistry
• Biochemistry and Cell Biology
• +۸ مورد دیگر

Paula T. Hammond is the David H. Koch Professor of Engineering, head of the Department of Chemical Engineering, and a member of the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. A pioneer in nanotechnology and polymer science, she develops layer-by-layer (LbL) nanoparticle platforms for cancer therapy, wound healing, vaccine delivery, and synthetic blood substitutes. Her work bridges chemical engineering, materials science, and biomedical applications with a focus on translational research. BS in Chemical Engineering, MIT (1984) MS in Chemical Engineering, Georgia Tech (1988) PhD in Chemical Engineering, MIT (1993) Research Interests : Hammond’s research spans nano-based drug delivery , immunotherapy , biomedical implants , and self-assembling materials . Her lab designs LbL nanoparticles for ovarian cancer , glioblastoma , and intractable cancers , enabling combination therapies (siRNA, proteins, chemotherapy). Recent work includes ML-driven nanoparticle design and two-component hemostatic systems for internal bleeding. Article Trends : Her recent publications (2025) emphasize modular LbL nanoparticles for hematopoietic stem cells , cancer immunostimulation , and multi-drug delivery . Broader keywords include Nanotechnology , Biomaterials , RNA Therapeutics , while sub-fields cover targeted drug release , immune activation , and synthetic oxygen transport . Scientific Awards : National Medal of Technology and Innovation (2024) Othmer Gold Medal (2024) Benjamin Franklin Medal in Chemistry (2024) James R. Killian Faculty Achievement Award (2023-24) MIT Institute Professor (2021) Three-time National Academy member (Sciences, Engineering, Medicine) Advising & Leadership : Hammond has mentored over 60 graduate students and postdocs , co-founded LayerBio, Inc. , and serves on scientific advisory boards for Moderna and Burroughs-Wellcome Fund . She chairs MIT’s Initiative on Faculty Race and Diversity and contributes to national science policy through PCAST. Lab & Collaborations : The Hammond Lab at MIT’s Koch Institute develops LbL nanoparticle systems with applications in cancer, regenerative medicine, and hemostasis. Collaborations include the MIT Institute for Soldier Nanotechnology and partnerships with clinicians, biologists, and engineers.

• Nanotechnology
• Chemical Engineering
• Drug Delivery
• +۱۲ مورد دیگر

Can Chen is an Assistant Professor in the School of Data Science and Society at the University of North Carolina at Chapel Hill, with adjunct appointments in the Department of Mathematics (College of Arts & Sciences) and the Department of Biostatistics (Gillings School of Global Public Health). He holds core faculty status in the Carolina Health Informatics Program and is affiliated with the Computational Medicine Program and Carolina Center for Interdisciplinary Applied Mathematics. Education: B.S. in Mathematics (UC Irvine, 2016), M.S. in Electrical & Computer Engineering (UMichigan, 2020), Ph.D. in Applied & Interdisciplinary Mathematics (UMichigan, 2021), followed by a postdoc at Brigham and Women’s Hospital/Harvard Medical School (2021–2023). Research interests span control theory, network science, tensor algebra, numerical analysis, machine learning, computational biology, and hypergraph learning. Notable contributions include theoretical frameworks for ecological systems stability, tensor-based dynamical systems, and hypergraph learning applied to genome-scale metabolic networks. Recent work includes a Physics Reports review on ecological stability, a Springer book on tensor algebra, and a Nature Communications paper introducing CHESHIRE for metabolic network analysis. His lab focuses on developing computational tools for systems biology and translational medicine. Key collaborations involve proteogenomic approaches to cancer biomarker discovery, E3 ligase-based targeted therapy, and signal transduction pathways in oncology. He currently oversees research on protein degradation mechanisms, immune-oncology, and systems-driven drug development.

• control theory
• network science
• tensor algebra
• +۷ مورد دیگر